- Home
- CRIS vs AIXC Comparison
CRIS vs AIXC Comparison
Compare CRIS & AIXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | AIXC |
|---|---|---|
| Founded | 2000 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 20.3M |
| IPO Year | 2000 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CRIS | AIXC |
|---|---|---|
| Price | $0.99 | $1.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | 117.7K | ★ 436.7K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | 53.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | $4,983,556.00 |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $67.74 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.18 | $0.59 |
| 52 Week High | $6.74 | $3.14 |
Technical Indicators
Market Signals| Indicator | CRIS | AIXC |
|---|---|---|
| Relative Strength Index (RSI) | 20.56 | 60.50 |
| Support Level | $0.95 | $1.02 |
| Resistance Level | $1.04 | $1.45 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 4.04 | 88.99 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About AIXC AIxCrypto Holdings Inc.
AIxCrypto Holdings Inc is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The Company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets (RWA) and the deployment of Embodied Artificial Intelligence (EAI) in commercial environments. Its mission is to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems.